Published in J Neurol Neurosurg Psychiatry on September 01, 2003
Pyridostigmine for treatment of neurogenic orthostatic hypotension [correction of hypertension]--a follow-up survey study. Clin Auton Res (2005) 2.15
Management of neurogenic orthostatic hypotension: an update. Lancet Neurol (2008) 2.03
Review: cerebral microvascular pathology in ageing and neurodegeneration. Neuropathol Appl Neurobiol (2011) 1.91
Comparative efficacy of yohimbine against pyridostigmine for the treatment of orthostatic hypotension in autonomic failure. Hypertension (2010) 1.69
Preventing and treating orthostatic hypotension: As easy as A, B, C. Cleve Clin J Med (2010) 1.19
Management of the hospitalized patient with Parkinson's disease: current state of the field and need for guidelines. Parkinsonism Relat Disord (2010) 1.16
Invited Article: Autonomic ganglia: target and novel therapeutic tool. Neurology (2008) 1.15
Current concepts in orthostatic hypotension management. Curr Hypertens Rep (2013) 1.13
The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic orthostatic hypotension and associated supine hypertension. J Neurol (2017) 1.09
Pyridostigmine in the treatment of orthostatic hypotension. Clin Auton Res (2005) 1.08
A randomised controlled study of the effect of cholinesterase inhibition on colon function in patients with diabetes mellitus and constipation. Gut (2012) 0.94
Dysautonomia: perioperative implications. Anesthesiology (2012) 0.94
Evaluation and treatment of orthostatic hypotension. J Am Soc Hypertens (2013) 0.89
Pharmacotherapy of autonomic failure. Pharmacol Ther (2011) 0.84
Comprehensive treatment of dementia with Lewy bodies. Alzheimers Res Ther (2015) 0.80
Acetylcholinesterase inhibition and orthostatic hypotension. Clin Auton Res (2006) 0.79
Current pharmacologic treatment for orthostatic hypotension. Clin Auton Res (2008) 0.78
Management of multiple system atrophy: state of the art. J Neural Transm (Vienna) (2005) 0.78
Pyridostigmine in autonomic failure: can we treat postural hypotension and bladder dysfunction with one drug? Clin Auton Res (2006) 0.78
Acetylcholinesterase activity, cohabitation with floricultural workers, and blood pressure in Ecuadorian children. Environ Health Perspect (2013) 0.78
Acetylcholinesterase inhibition in the treatment of hypotension. J Neurol Neurosurg Psychiatry (2003) 0.77
Effects of patient-controlled abdominal compression on standing systolic blood pressure in adults with orthostatic hypotension. Arch Phys Med Rehabil (2014) 0.77
Orthostatic responses to anticholinesterase inhibition in spinal cord injury. Clin Auton Res (2015) 0.75
Multiple system atrophy: using clinical pharmacology to reveal pathophysiology. Clin Auton Res (2015) 0.75
Orthostatic hypotension: managing a difficult problem. Expert Rev Cardiovasc Ther (2015) 0.75
Enhanced Cholinergic Activity Improves Cerebral Blood Flow during Orthostatic Stress. Front Neurol (2017) 0.75
Evidence-based treatment of neurogenic orthostatic hypotension and related symptoms. J Neural Transm (Vienna) (2017) 0.75
Autonomic Dysfunction in Cardiology: Pathophysiology, Investigation, and Management. Can J Cardiol (2017) 0.75
Functional organization of central pathways regulating the cardiovascular system. Physiol Rev (1994) 3.65
Composite autonomic scoring scale for laboratory quantification of generalized autonomic failure. Mayo Clin Proc (1993) 3.40
Efficacy of midodrine vs placebo in neurogenic orthostatic hypotension. A randomized, double-blind multicenter study. Midodrine Study Group. JAMA (1997) 2.63
Human sympathetic and vagal baroreflex responses to sequential nitroprusside and phenylephrine. Am J Physiol (1999) 2.30
The appropriateness of analysis of variance and multiple-comparison procedures. Biometrics (1983) 1.89
Autonomic nervous system function. J Clin Neurophysiol (1993) 1.85
Prospective evaluation of clinical characteristics of orthostatic hypotension. Mayo Clin Proc (1995) 1.75
A double-blind, dose-response study of midodrine in neurogenic orthostatic hypotension. Neurology (1998) 1.67
Mineralocorticoid-induced hypertension in patients with orthostatic hypotension. N Engl J Med (1979) 1.53
Pathophysiological basis of orthostatic hypotension in autonomic failure. J Physiol (1999) 1.35
The hypertension of autonomic failure and its treatment. Hypertension (1997) 1.18
Gastrointestinal motility disturbances in patients with orthostatic hypotension. Gastroenterology (1985) 1.16
Recent advances in the treatment of orthostatic hypotension. Neurology (1995) 1.04
Arterial pressure ramps provoke linear increases of heart period in humans. Am J Physiol (1986) 0.96
The non-invasive assessment of stroke volume and cardiac output by impedance cardiography: a review. Aviat Space Environ Med (1999) 0.96
Pyridostigmine bromide and constipation in Parkinson's disease. JAMA (1983) 0.90
Rational therapy of myasthenia gravis. Semin Neurol (1990) 0.89
Noradrenaline response to edrophonium in primary autonomic failure: distinction between central and peripheral damage. Lancet (1988) 0.89
Measurement of human sympathetic nervous responses to stressors by microneurography. J Auton Nerv Syst (1994) 0.88
Cholinergic stimulation with pyridostigmine blunts the cardiac responses to mental stress. Clin Auton Res (1999) 0.84
Clinical autonomic neuropharmacology. Neurol Clin (1990) 0.83
Bradycardia produced by pyridostigmine and physostigmine. Can J Anaesth (1997) 0.82
Lowered norepinephrine turnover as a sign of impaired ganglionic transmission after preganglionic lesioning by acetylcholinesterase antibodies. J Pharmacol Exp Ther (1996) 0.82
Human temperature regulation during exercise after oral pyridostigmine administration. Aviat Space Environ Med (1990) 0.81
Catecholamine release and excretion in rats with immunologically induced preganglionic sympathectomy. J Neurochem (1994) 0.81
Chronic pyridostigmine bromide administration: side effects among soldiers working in a desert environment. Mil Med (1992) 0.80
Second consensus statement on the diagnosis of multiple system atrophy. Neurology (2008) 7.27
Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci (1999) 5.01
Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies. N Engl J Med (2000) 3.57
Plasma exchange in polyneuropathy associated with monoclonal gammopathy of undetermined significance. N Engl J Med (1991) 3.29
The Autonomic Symptom Profile: a new instrument to assess autonomic symptoms. Neurology (1999) 3.09
Idiopathic postural orthostatic tachycardia syndrome: an attenuated form of acute pandysautonomia? Neurology (1993) 2.92
Quantitative sudomotor axon reflex test in normal and neuropathic subjects. Ann Neurol (1983) 2.90
Effect of age and gender on sudomotor and cardiovagal function and blood pressure response to tilt in normal subjects. Muscle Nerve (1997) 2.86
Utility of thermography in the diagnosis of lumbosacral radiculopathy. Neurology (1991) 2.66
Value of autonomic testing in reflex sympathetic dystrophy. Mayo Clin Proc (1995) 2.65
Postural tachycardia syndrome (POTS). Neurology (1995) 2.59
Variables influencing neuropathic endpoints: the Rochester Diabetic Neuropathy Study of Healthy Subjects. Neurology (1995) 2.42
The sympathetic nervous system in diabetic neuropathy. A clinical and pathological study. Brain (1975) 2.20
American Neurogastroenterology and Motility Society consensus statement on intraluminal measurement of gastrointestinal and colonic motility in clinical practice. Neurogastroenterol Motil (2008) 2.16
Waiting for platelet counts causes unsubstantiated delay of thrombolysis therapy. Eur Neurol (2013) 2.13
Validating biomarkers of treatable mechanisms in irritable bowel syndrome. Neurogastroenterol Motil (2014) 2.11
Ataxic sensory neuropathy and dorsal root ganglionitis associated with Sjögren's syndrome. Ann Neurol (1990) 1.92
3,4-Diaminopyridine in the treatment of Lambert-Eaton myasthenic syndrome. N Engl J Med (1989) 1.89
Thermoregulatory sweating abnormalities in diabetes mellitus. Mayo Clin Proc (1989) 1.85
Nonsystemic vasculitic neuropathy. Brain (1987) 1.84
Differentiation of Parkinson's disease and multiple system atrophy in early disease stages by means of I-123-MIBG-SPECT. J Neurol Sci (2000) 1.79
Prednisone improves chronic inflammatory demyelinating polyradiculoneuropathy more than no treatment. Ann Neurol (1982) 1.77
Depletion of catecholaminergic neurons of the rostral ventrolateral medulla in multiple systems atrophy with autonomic failure. Ann Neurol (1998) 1.76
Plasma exchange in chronic inflammatory demyelinating polyradiculoneuropathy. N Engl J Med (1986) 1.75
Meckel's diverticulum causing intestinal obstruction. Am J Gastroenterol (2001) 1.75
Prospective evaluation of clinical characteristics of orthostatic hypotension. Mayo Clin Proc (1995) 1.75
Postural tachycardia syndrome: clinical features and follow-up study. Mayo Clin Proc (1999) 1.74
Performance characteristics of scintigraphic colon transit measurement in health and irritable bowel syndrome and relationship to bowel functions. Neurogastroenterol Motil (2009) 1.73
Endoneurial blood flow and oxygen tension in the sciatic nerves of rats with experimental diabetic neuropathy. Brain (1984) 1.69
A plasma exchange versus immune globulin infusion trial in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol (1994) 1.68
Influence of posture on the Valsalva manoeuvre. Clin Sci (Lond) (2001) 1.67
A double-blind, dose-response study of midodrine in neurogenic orthostatic hypotension. Neurology (1998) 1.67
Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a meta-analysis. Diabet Med (2004) 1.65
Medical records documentation of constipation preceding Parkinson disease: A case-control study. Neurology (2009) 1.64
Clinical phenotypes of different MPZ (P0) mutations may include Charcot-Marie-Tooth type 1B, Dejerine-Sottas, and congenital hypomyelination. Neuron (1996) 1.58
Idiopathic autonomic neuropathy: clinical, neurophysiologic, and follow-up studies on 27 patients. Neurology (1994) 1.47
Basal forebrain malformation with hyperhidrosis and hypothermia: variant of Shapiro's syndrome. Neurology (2001) 1.46
[Female sexual dysfunction: a systematic overview of classification, pathophysiology, diagnosis and treatment]. Fortschr Neurol Psychiatr (2004) 1.46
Autonomic involvement in extrapyramidal and cerebellar disorders. Clin Auton Res (1991) 1.44
Hypocapnia and cerebral hypoperfusion in orthostatic intolerance. Stroke (1998) 1.44
The Rochester Diabetic Neuropathy Study: design, criteria for types of neuropathy, selection bias, and reproducibility of neuropathic tests. Neurology (1991) 1.43
Pro- and anti-inflammatory cytokine gene expression in rat sciatic nerve chronic constriction injury model of neuropathic pain. Exp Neurol (2001) 1.42
The Rochester Diabetic Neuropathy Study: reassessment of tests and criteria for diagnosis and staged severity. Neurology (1992) 1.38
Pharmacological dissection of components of the Valsalva maneuver in adrenergic failure. J Appl Physiol (1985) (1991) 1.36
Pathophysiological basis of orthostatic hypotension in autonomic failure. J Physiol (1999) 1.35
Autoregulation of cerebral blood flow in orthostatic hypotension. Stroke (1998) 1.35
Gastroparesis and functional dyspepsia: excerpts from the AGA/ANMS meeting. Neurogastroenterol Motil (2009) 1.32
Magnetic resonance imaging of anatomic and dynamic defects of the pelvic floor in defecatory disorders. Am J Gastroenterol (2003) 1.31
Nerve blood flow in early experimental diabetes in rats: relation to conduction deficits. Am J Physiol (1991) 1.31
Performance characteristics of scintigraphic measurement of gastric emptying of solids in healthy participants. Neurogastroenterol Motil (2012) 1.31
Lipoic acid improves nerve blood flow, reduces oxidative stress, and improves distal nerve conduction in experimental diabetic neuropathy. Diabetes Care (1995) 1.31
Prevalence of Parkinson's disease in the Parsi community of Bombay, India. Arch Neurol (1988) 1.30
Baroreflex control of muscle sympathetic nerve activity in postural orthostatic tachycardia syndrome. Am J Physiol Heart Circ Physiol (2005) 1.29
Cholinergic stimulation enhances colonic motor activity, transit, and sensation in humans. Am J Physiol Gastrointest Liver Physiol (2001) 1.28
Autonomic dysfunction in dementia with Lewy bodies. Neurology (2004) 1.25
Consensus statement on the diagnosis of multiple system atrophy. J Auton Nerv Syst (1998) 1.25
Charcot-Marie-Tooth disease with Leber optic atrophy. Neurology (1978) 1.21
Ischemic conduction failure and energy metabolism in experimental diabetic neuropathy. Am J Physiol (1985) 1.20
The sympathetic nervous system in alcoholic neuropathy. A clinical and pathological study. Brain (1975) 1.20
Effects of changes of blood pressure, respiratory acidosis and hypoxia on blood flow in the sciatic nerve of the rat. J Physiol (1984) 1.20
Evaluation of skin vasomotor reflexes by using laser Doppler velocimetry. Mayo Clin Proc (1983) 1.20
Evaluation of distal symmetric polyneuropathy: the role of autonomic testing, nerve biopsy, and skin biopsy (an evidence-based review). Muscle Nerve (2009) 1.19
Distal small fiber neuropathy: results of tests of sweating and autonomic cardiovascular reflexes. Muscle Nerve (1992) 1.19
Autonomic dysfunction in gastrointestinal motility disorders. Gut (1993) 1.18
Mesopontine cholinergic neuron involvement in Lewy body dementia and multiple system atrophy. Neurology (2008) 1.18
Autoimmune autonomic ganglionopathy: IgG effects on ganglionic acetylcholine receptor current. Neurology (2007) 1.16
Effect of female sex hormone supplementation and withdrawal on gastrointestinal and colonic transit in postmenopausal women. Neurogastroenterol Motil (2006) 1.15
Chronic idiopathic anhidrosis. Ann Neurol (1985) 1.14
Increased endoneurial fluid pressure in experimental lead neuropathy. Nature (1977) 1.14
Comparison of the postural tachycardia syndrome (POTS) with orthostatic hypotension due to autonomic failure. J Auton Nerv Syst (1994) 1.14
Experimental chronic hypoxic neuropathy: relevance to diabetic neuropathy. Am J Physiol (1986) 1.13
Small fiber dysfunction predominates in Fabry neuropathy. J Clin Neurophysiol (2002) 1.13
Interictal cardiac autonomic dysfunction in temporal lobe epilepsy demonstrated by [(123)I]metaiodobenzylguanidine-SPECT. Brain (2001) 1.13
Efficacy of immunotherapy in seropositive and seronegative putative autoimmune autonomic ganglionopathy. Neurology (2009) 1.12
Prospective evaluation of somatic and autonomic small fibers in selected autonomic neuropathies. Neurology (2004) 1.12
Prevalence of peripheral neuropathy in the Parsi community of Bombay. Neurology (1991) 1.12
Prednisone-responsive hereditary motor and sensory neuropathy. Mayo Clin Proc (1982) 1.12
Acute panautonomic neuropathy. Ann Neurol (1983) 1.11
Vasovagal syncope. Ann Intern Med (2000) 1.11
Insights into the pathophysiology and mechanisms of constipation, irritable bowel syndrome, and diverticulosis in older people. J Am Geriatr Soc (2000) 1.11
Lack of global vagal propensity in patients with oculocardiac reflex. Ophthalmology (1994) 1.11
Permanent axotomy, a model of axonal atrophy and secondary segmental demyelination and remyelination. Ann Neurol (1981) 1.11
Positive neuropathic sensory symptoms as endpoints in diabetic neuropathy trials. J Neurol Sci (2001) 1.10
Prevalence of epilepsy in the Parsi community of Bombay. Epilepsia (1988) 1.10
Prevalence of multiple sclerosis in the Parsis of Bombay. Neurology (1988) 1.09
Evaluation of distal symmetric polyneuropathy: the role of laboratory and genetic testing (an evidence-based review). Muscle Nerve (2009) 1.09
Normative data on phases of the Valsalva maneuver. J Clin Neurophysiol (1998) 1.08